Scambia G - Search Results

1

Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives.

Musacchio L, Cicala CM, Salutari V, Camarda F, Carbone MV, Ghizzoni V, Giudice E, Nero C, Perri MT, Ricci C, Tronconi F, Scambia G, Lorusso D. Musacchio L, et al. Among authors: scambia g. Front Oncol. 2022 Feb 23;12:831612. doi: 10.3389/fonc.2022.831612. eCollection 2022. Front Oncol. 2022. PMID: 35280728 Free PMC article. Review.

2

Phase I study of gemcitabine and liposomal doxorubicin in relapsed ovarian cancer.

D'Agostino G, Ferrandina G, Garganese G, Salerno MG, Lorusso D, Farnetano MG, Mancuso S, Scambia G. D'Agostino G, et al. Among authors: scambia g. Oncology. 2002;62(2):110-4. doi: 10.1159/000048255. Oncology. 2002. PMID: 11914595 Clinical Trial.

3

Cyclooxygenase-2 expression in lymph node metastasis of cervical and vulvar cancer.

Ferrandina G, Ranelletti FO, Lauriola L, Zannoni GF, Legge F, Gessi M, Salutari V, Scambia G. Ferrandina G, et al. Among authors: scambia g. Oncol Rep. 2003 Nov-Dec;10(6):1799-804. Oncol Rep. 2003. PMID: 14534699

4

Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study.

Ferrandina G, Ranelletti FO, Legge F, Lauriola L, Salutari V, Gessi M, Testa AC, Werner U, Navarra P, Tringali G, Battaglia A, Scambia G. Ferrandina G, et al. Among authors: scambia g. Clin Cancer Res. 2003 Oct 1;9(12):4324-31. Clin Cancer Res. 2003. PMID: 14555502 Clinical Trial.

5

Gemcitabine: current role and future options in the treatment of ovarian cancer.

Fruscella E, Gallo D, Ferrandina G, D'Agostino G, Scambia G. Fruscella E, et al. Among authors: scambia g. Crit Rev Oncol Hematol. 2003 Oct;48(1):81-8. doi: 10.1016/s1040-8428(03)00119-7. Crit Rev Oncol Hematol. 2003. PMID: 14585485 Review.

6

Impact of interval debulking surgery on clinical outcome in primary unresectable FIGO stage IIIc ovarian cancer patients.

Fanfani F, Ferrandina G, Corrado G, Fagotti A, Zakut HV, Mancuso S, Scambia G. Fanfani F, et al. Among authors: scambia g. Oncology. 2003;65(4):316-22. doi: 10.1159/000074644. Oncology. 2003. PMID: 14707451

7

Lymphocyte composition of tumor draining lymph nodes from cervical and endometrial cancer patients.

Fattorossi A, Battaglia A, Ferrandina G, Buzzonetti A, Legge F, Salutari V, Scambia G. Fattorossi A, et al. Among authors: scambia g. Gynecol Oncol. 2004 Jan;92(1):106-15. doi: 10.1016/j.ygyno.2003.09.020. Gynecol Oncol. 2004. PMID: 14751146

8

Expression of cyclooxygenase-2 (COX-2) in non-neoplastic and neoplastic vulvar epithelial lesions.

Ferrandina G, Ranelletti FO, Salutari V, Gessi M, Legge F, Zannoni GF, Scambia G, Lauriola L. Ferrandina G, et al. Among authors: scambia g. Gynecol Oncol. 2004 Feb;92(2):537-44. doi: 10.1016/j.ygyno.2003.10.054. Gynecol Oncol. 2004. PMID: 14766245

9

Prognostic role of the ratio between cyclooxygenase-2 in tumor and stroma compartments in cervical cancer.

Ferrandina G, Ranelletti FO, Legge F, Gessi M, Salutari V, Distefano MG, Lauriola L, Zannoni GF, Martinelli E, Scambia G. Ferrandina G, et al. Among authors: scambia g. Clin Cancer Res. 2004 May 1;10(9):3117-23. doi: 10.1158/1078-0432.ccr-1090-3. Clin Cancer Res. 2004. PMID: 15131052

10

Cyclooxygenase-2 expression in borderline ovarian tumors.

Ferrandina G, Zannoni GF, Ranelletti FO, Legge F, Gessi M, Salutari V, Gallotta V, Lauriola L, Scambia G. Ferrandina G, et al. Among authors: scambia g. Gynecol Oncol. 2004 Oct;95(1):46-51. doi: 10.1016/j.ygyno.2004.07.005. Gynecol Oncol. 2004. PMID: 15385109

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,081 results

Search Page

Filters